US Patent 7265089 KGF polypeptide compositions
Patent 7265089 was granted and assigned to Chiron Corporation on September, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+379 characters)
Article
Patent abstract
Compositions comprising keratinocyte growth factor (KGF) polypeptides and methods of using the same are described. The KGF polypeptides of the present invention display enhanced bioactivity relative to full-length KGF163. Accordingly, the KGF polypeptides of the present invention may be used in compositions in lesser amounts than would be necessary using KGF163.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07265089 KGF polypeptide compositions US Patent 7265089 KGF polypeptide compositions
Infobox
Patent Number
0726508900
Patent Number
726508900
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072650890
Date of Patent
September 4, 2007
0Patent Application Number
102271850
Date Filed
August 21, 2002
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072650890
Date of Patent
September 4, 2007
0Patent Application Number
102271850
Date Filed
August 21, 2002
0Official Website
Patent Primary Examiner
Edits on 16 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07265089 KGF polypeptide compositions
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07265089
Date of patent
September 4, 2007
Patent application number
10227185
Date Filed
August 21, 2002
Patent primary examiner
Find more entities like US Patent 7265089 KGF polypeptide compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
